journal article·2014-07

Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer

Shan Tang, Qi Yin, Zhiwen Zhang, Wangwen Gu, Lingli Chen, Haijun Yu, Yongzhuo Huang, Xianzhi Chen, Minghua Xu, Yaping Li

Biomaterials· Volume 35· Issue 23
Publisher page

Abstract

An appropriate co-delivery system for chemotherapeutic agents and nucleic acid drugs will provide a more efficacious approach for the treatment of breast cancer by reversing multidrug resistance (MDR). In this work, a new amphiphilic poly (β-amino ester), poly[(1,4-butanediol)-diacrylate-β-5-polyethylenimine]-block-poly[(1,4-butanediol)-diacrylate-β-5-hydroxy amylamine] (PDP-PDHA) was synthesized, and the doxorubicin (DOX) and survivin-targeting shRNA (shSur) co-loading nanoparticle (PDNs) were prepared. The pH-sensitive poly[(1,4-butanediol) diacrylate-β-5-hydroxy amylamine] (PDHA) endowed PDNs both pH-triggered drug release characteristics and enhanced endo/lysosomal escape ability, thus improving the cytotoxicity of DOX and the transfection efficiency. PDNs also increased the DOX accumulation, down-regulated 57.7% survivin expression, induced 80.8% cell apoptosis and changed the cell cycle in MCF-7/ADR cells. In the MCF-7/ADR tumor-bearing mice models, after administrated intravenously, PDNs raised the accumulation of DOX and shSur in the tumor tissue by 10.4 and 20.2 folds, respectively, resulting in obvious inhibition of the tumor growth with tumor inhibiting rate of 95.9%. The combination of DOX and RNA interference showed synergistic effect on overcoming MDR. Therefore, PDNs could be a promising co-delivery vector for effective therapy of drug resistant breast cancer.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (30)

Show source-provided references
1. Targeting multidrug resistance in cancer10.1038/nrd1984 ↗
2. Mechanisms of cancer drug resistance10.1146/annurev.med.53.082901.103929 ↗
3. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
4. Nanotechnology applications in cancer10.1146/annurev.bioeng.9.060906.152025 ↗
5. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR110.1038/sj.gt.3302269 ↗
6. Short interfering RNAs as a tool for cancer gene therapy10.1038/sj.cgt.7700791 ↗
7. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram10.1021/nn4010796 ↗
8. Gene and doxorubicin co-delivery system for targeting therapy of glioma10.1016/j.biomaterials.2012.03.031 ↗
9. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer10.1038/nmat1737 ↗
10. Co-delivery of doxorubicin and bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells10.1002/smll.200900621 ↗
11. Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate10.1007/s11095-008-9608-1 ↗
12. Rapid optimization of gene delivery by parallel end-modification of poly(beta-amino ester)s10.1038/sj.mt.6300132 ↗
13. A combinatorial polymer library approach yields insight into nonviral gene delivery10.1021/ar7002336 ↗
14. Gene delivery properties of end-modified poly(beta-amino ester)s10.1021/bc7002082 ↗
15. Self-assembled carboxymethyl poly (L-histidine) coated poly (beta-amino ester)/DNA complexes for gene transfection10.1016/j.biomaterials.2011.09.076 ↗
16. Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors10.1038/gt.2008.182 ↗
17. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer10.1016/j.biomaterials.2012.08.007 ↗
18. Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells10.1021/nl062395b ↗
19. Lactosylated chitosan for DNA delivery into hepatocytes: the effect of lactosylation on the physicochemical properties and intracellular trafficking of pDNA/chitosan complexes10.1021/bc050228h ↗
20. Self-cross-linked polymer nanogels: a versatile nanoscopic drug delivery platform10.1021/ja1069932 ↗
21. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery10.1016/j.jconrel.2010.08.027 ↗
22. Nanoparticles in cancer therapy and diagnosis10.1016/S0169-409X(02)00044-3 ↗
23. Effect of surface properties on nanoparticle-cell interactions10.1002/smll.200901158 ↗
24. Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions10.1021/mp300281t ↗
25. Flip-flop of doxorubicin across erythrocyte and lipid membranes10.1016/S0006-2952(97)00326-2 ↗
26. Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanism10.1016/j.bcp.2005.03.032 ↗
27. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors10.1016/j.ejpb.2007.09.002 ↗
28. Survivin expression and targeting in breast cancer10.1016/j.suronc.2011.01.001 ↗
29. Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(beta-amino esters)10.1016/j.biomaterials.2012.05.039 ↗
30. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of p-glycoprotein, fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins)10.1016/S0304-3835(01)00834-5 ↗